Regenerative Medicine
Based in Research & Investing in Clients
Through our network of nationwide physicians, active clinical trials, partnerships with medical and scientific institutions, and research based in real client results, Celltex is leading the United States into the future of regenerative medicine through adult stem cells.
While results vary, up to 80% of MS, Parkinson’s and arthritis clients have reported improvement in one or more symptom areas.
Learn more about past client results by visiting our Client Results page, and to hear stories from clients themselves, visit our Client Stories page.
Case Studies
Published Studies on Celltex Clients
To further our commitment to lead the United States in the advancement of regenerative medicine through the use of autologous stem cells, we are continually pursuing research, studies and clinical trials to help the world learn more about the application of adult stem cells for various medical conditions.
Autologous Adipose Stem Cell Therapy for Autonomic Nervous System Dysfunction in Two Young Patients
Mohammed T. Numan, Ankur Kamdar, Jane Young, and Ian. J. Butler
This case study reports the clinical experience in two young patients with severe symptoms caused by autonomic dysfunction and autoimmune disease who underwent autologous ASC therapy.
Download the StudyInfusion of Autologous, Culture-Expanded, Adipose-Derived Mesenchymal Stem Cells in the Treatment of Coexisting Autoimmune Disease
Sarah V. Kelly, MD, and Jane S. Young, MD, PhD
Celltex Chief Scientific Officer, Dr. Jane Young, MD, PhD, together with a physician, Sarah V. Kelly, MD, authored this case study, which focuses on a rheumatoid arthritis patient with coexisting autoimmune disease who is responding favorably to autologous mesenchymal stem cell therapy using stem cells processed by Celltex.
Download the StudyClinical Research
Investing in the Future With Industry Partnerships
Celltex has begun the clinical trial process with esteemed medical and scientific institutions.
Alzheimer’s Research
Alzheimer’s Research Partnership With Texas A&M University for a Multiyear Alzheimer’s Research Study
We call the project “A Future to Remember,” and we are studying potential therapy using allogeneic MSC-derived exosomes with Texas A&M College.
Rheumatoid Arthritis & Osteoarthritis
Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and Osteoarthritis
Trial sponsor in collaboration with Hospital Galenia on a clinical trial authorized by COFEPRIS (Federal Commission for the Protection against Sanitary Risk), Mexico’s FDA equivalent.
Client Testimonials
View Real Client Stories
Dysautonomia Autoimmune Diseases
I am feeling the absolute best I have since my diagnosis. I truly cannot thank Celltex and Dr. Jones enough for the wonderful work they do to help people like me.
Kelsi Wells
Read the Story
Peripheral Vascular Disease Vascular Disease
I knew that it was time to find a resolution so that I could get back to doing the things I love with the people I love.
Frank Brown
Read the Story
Vascular Malformations Vascular Disease
Since August 2017, I have not experienced any seizures. Today, I am traveling the country and enjoying a newfound life that allows me to continue helping others.
Robert Potts
Read the StoryRegenerative Medicine
A Proven Alternative for Patients
An opportunity for their physicians.
Celltex partners with physicians to offer a safe, responsible clinical care plan for stem cell therapy. We culture mesenchymal stem cells derived from one’s own stem cells for therapeutic use. This unique ability provides physicians the potential to help treat chronic conditions and more. We invite you to join this exciting new science and potentially give your patients a proven answer to their chronic conditions.
Learn More